1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe GMP Cell Therapy Consumables Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe GMP Cell Therapy Consumables Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe GMP Cell Therapy Consumables Market Regional Analysis
6.2 Europe GMP Cell Therapy Consumables Market Revenue 2020-2028 (US$ Million)
6.3 Europe GMP Cell Therapy Consumables Market Forecast Analysis
7. Europe GMP Cell Therapy Consumables Market Analysis – by Product
7.1 Kits
- 7.1.1 Overview
- 7.1.2 Kits: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Reagents/Molecular Biology Reagents
- 7.2.1 Overview
- 7.2.2 Reagents/Molecular Biology Reagents: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Growth Factors/Cytokines
- 7.3.1 Overview
- 7.3.2 Growth Factors/Cytokines: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Interleukins
- 7.4.1 Overview
- 7.4.2 Interleukins: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Europe GMP Cell Therapy Consumables Market Analysis – by Cell Therapy
8.1 NK Cell Therapy
- 8.1.1 Overview
- 8.1.2 NK Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Stem Cell Therapy
- 8.2.1 Overview
- 8.2.2 Stem Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 T-Cell Therapy
- 8.3.1 Overview
- 8.3.2 T-Cell Therapy: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Europe GMP Cell Therapy Consumables Market Analysis – by Process
9.1 Cell Collection and Characterization/Sorting and Separation
- 9.1.1 Overview
- 9.1.2 Cell Collection and Characterization/Sorting and Separation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Cell Culture and Expansion/Preparation
- 9.2.1 Overview
- 9.2.2 Cell Culture and Expansion/Preparation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Cryopreservation
- 9.3.1 Overview
- 9.3.2 Cryopreservation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Cell Processing and Formulation
- 9.4.1 Overview
- 9.4.2 Cell Processing and Formulation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.5 Cell Isolation and Activation
- 9.5.1 Overview
- 9.5.2 Cell Isolation and Activation: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.6 Cell Distribution/Handling
- 9.6.1 Overview
- 9.6.2 Cell Distribution/Handling: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.7 Process Monitoring
- 9.7.1 Overview
- 9.7.2 Process Monitoring: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.8 Control/Readministration/Quality Assurance
- 9.8.1 Overview
- 9.8.2 Control/Readministration/Quality Assurance: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Europe GMP Cell Therapy Consumables Market Analysis – by End Use
10.1 Clinical
- 10.1.1 Overview
- 10.1.2 Clinical: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Commercial
- 10.2.1 Overview
- 10.2.2 Commercial: Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.3 Research
- 10.3.1 Overview
- 10.3.2 Research : Europe GMP Cell Therapy Consumables Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. Europe GMP Cell Therapy Consumables Market – Europe Analysis
11.1 Overview
11.2 Europe
- 11.2.1 Europe GMP Cell Therapy Consumables Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 11.2.1.1 Europe GMP Cell Therapy Consumables Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 UK:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 UK: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 11.2.1.1.2 UK: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 11.2.1.1.3 UK: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 11.2.1.1.4 UK: Europe GMP Cell Therapy Consumables Market Breakdown, by End Use
- 11.2.1.2 Germany:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Germany: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 11.2.1.2.2 Germany: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 11.2.1.2.3 Germany: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 11.2.1.2.4 Germany: Europe GMP Cell Therapy Consumables Market Breakdown, by End Use
- 11.2.1.3 France:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 France: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 11.2.1.3.2 France: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 11.2.1.3.3 France: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 11.2.1.3.4 France: Europe GMP Cell Therapy Consumables Market Breakdown, by End Use
- 11.2.1.4 Russia:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Russia: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 11.2.1.4.2 Russia: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 11.2.1.4.3 Russia: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 11.2.1.4.4 Russia: Europe GMP Cell Therapy Consumables Market Breakdown, by End Use
- 11.2.1.5 Italy:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.5.1 Italy: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 11.2.1.5.2 Italy: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 11.2.1.5.3 Italy: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 11.2.1.5.4 Italy: Europe GMP Cell Therapy Consumables Market Breakdown, by End Use
- 11.2.1.6 Rest of Europe:
Europe GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe GMP Cell Therapy Consumables Market Breakdown, by Product
- 11.2.1.6.2 Rest of Europe: Europe GMP Cell Therapy Consumables Market Breakdown, by Cell Therapy
- 11.2.1.6.3 Rest of Europe: Europe GMP Cell Therapy Consumables Market Breakdown, by Process
- 11.2.1.6.4 Rest of Europe: Europe GMP Cell Therapy Consumables Market Breakdown, by End Use
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Bio-Techne Corp
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 BPS Bioscience Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Corning Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 FUJIFILM Irvine Scientific Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Global Life Sciences Solutions USA LLC
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Lonza Group AG
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Merck KGaA
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Miltenyi Biotec BV & Co KG
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Sartorius AG
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Thermo Fisher Scientific Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations